WeVote
Log In

Bill

Bill

S 493

Stop the ICC Act

119th Congress Introduced by Tom Cotton and 1 co-sponsor

Bill S 493 mandates health practitioners to discuss risks of certain pain medications with patients, enhancing informed consent and promoting safer prescribing practices.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 493

Summary of Bill S 493

Bill Information

  • Bill Number: S 493
  • Title: Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications
  • Status: Referred to Health
  • Introduced: January 08, 2025
  • Classification: Bill

Purpose and Intent

The primary purpose of Bill S 493 is to enhance patient safety and informed consent regarding the use of pain medications. The bill mandates that health practitioners must discuss the potential risks and side effects associated with specific pain medications with their patients prior to prescribing these drugs. This initiative aims to ensure that patients are fully aware of the implications of their treatment options, particularly in light of the ongoing concerns surrounding opioid use and addiction.

Key Provisions

  • Mandatory Discussion: Health practitioners are required to engage in a dialogue with patients about the risks associated with certain pain medications. This includes, but is not limited to, opioids and other high-risk pain management drugs.
  • Informed Consent: The bill emphasizes the importance of informed consent, ensuring that patients understand the potential for addiction, side effects, and alternative treatment options.
  • Documentation: Practitioners may be required to document the discussion in the patient's medical record to ensure compliance and accountability.

Who Would Be Affected

  • Patients: Individuals seeking pain management will benefit from increased awareness and understanding of the medications prescribed to them.
  • Health Practitioners: Doctors, nurses, and other healthcare providers will need to adjust their prescribing practices to comply with the new requirements, potentially impacting their workflow and patient interactions.
  • Healthcare System: The bill may lead to changes in how pain management is approached within healthcare settings, possibly influencing treatment protocols and patient education initiatives.

Procedural Aspects

  • Current Status: As of January 08, 2025, the bill has been referred to the Health Committee for further consideration.
  • Related Legislation: This bill is part of a broader legislative effort, with related bills from prior sessions (S 4277, S 6043, S 3521) and a companion bill (A 3116) indicating ongoing legislative interest in addressing pain management and medication safety.

Conclusion

Bill S 493 represents a significant step towards improving patient safety in the context of pain management. By requiring health practitioners to discuss the risks associated with certain pain medications, the bill aims to empower patients with knowledge and promote responsible prescribing practices. The outcome of this bill could have lasting implications for healthcare delivery and patient outcomes in the realm of pain management.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.